InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Ellingson Rachel, Directeur de la Stratégie. Director active across 2 companies, notably Zimmer Biomet Holdings, INC.. In total, 5 filings have been published. The latest transaction was filed on 1 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
311 shares
Common Stock
SEC:0001437749-22-014307:0·
14,730 shares
Common Stock
SEC:0001437749-22-011803:0·
0531 shares0
Common Stock
SEC:0001062993-22-011409:0·
0515 shares0
Common Stock
SEC:0001062993-21-004047·
0515 shares0
Common Stock
SEC:0001062993-21-004047:0·
5 of 5 declarations
About Ellingson Rachel
Rachel Ellingson serves as Senior Vice President and Chief Strategy Officer at Zimmer Biomet Holdings, Inc. and Biolife Solutions Inc. She is responsible for developing and implementing corporate strategies aimed at supporting growth and innovation. Rachel has extensive experience in strategic development and operational management, contributing to the achievement of organizational goals. Her role also involves collaborating with other executives to align strategic initiatives with the company's priorities.
